Is pharmacokinetically guided chemotherapy dosage a better way forward?
Bergh
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D019540:Area Under Curve; D016190:Carboplatin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013852:Thiotepa / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D003520:Cyclophosphamide; D013852:Thiotepa; D016190:Carboplatin